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Abstract
Multiple sclerosis (MS) is a chronic central nervous system disorder characterized by
white matter inflammation, demyelination and neurodegeneration. Although cognitive dys-
function is a common manifestation, it may go unnoticed in recently-diagnosed patients.
Prior studies suggest MS patients develop compensatory mechanisms potentially involving
enhanced performance monitoring. Here we assessed the performance monitoring system
in early-stage MS patients using the error-related negativity (ERN), an event-related brain
potential (ERP) observed following behavioral errors. Twenty-seven early-stage MS
patients and 31 controls were neuropsychologically assessed. Electroencephalography
recordings were obtained while participants performed: a) a stop task and b) an auditory
oddball task. Behavior and ERP measures were assessed. No differences in performance
were found between groups in most neuropsychological tests or in behavior or ERP compo-
nents in the auditory oddball task. However, the amplitude of the ERN associated with stop
errors in the stop task was significantly higher in patients. ERN amplitude correlated posi-
tively with scores on the Expanded Disability Status Scale and the Multiple Sclerosis Sever-
ity Score, and negatively with the time since last relapse. Patients showed higher neuronal
recruitment in tasks involving performance monitoring. Results suggest the development of
compensatory brain mechanisms in early-stage MS and reflect the sensitivity of the ERN to
detect these changes.
PLOS ONE | DOI:10.1371/journal.pone.0136786 August 31, 2015 1 / 15
OPEN ACCESS
Citation: López-Góngora M, Escartín A, Martínez-
Horta S, Fernández-Bobadilla R, Querol L, Romero
S, et al. (2015) Neurophysiological Evidence of
Compensatory Brain Mechanisms in Early-Stage
Multiple Sclerosis. PLoS ONE 10(8): e0136786.
doi:10.1371/journal.pone.0136786
Editor: Pablo Villoslada, Institute Biomedical
Research August Pi Sunyer (IDIBAPS)—Hospital
Clinic of Barcelona, SPAIN
Received: May 19, 2015
Accepted: August 6, 2015
Published: August 31, 2015
Copyright: © 2015 López-Góngora et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by Bayer
Hispania SL who was not involved in the conception
of the study, data collection or preparation of the
article. LQ is supported by a Juan Rodés research
contract (FIS JR13/00014) from the Instituto de Salud
Carlos III, Ministry of Economy and Competitiveness.
Competing Interests: The authors’ research group
received funding from Bayer Hispania SL to conduct
Introduction
Multiple sclerosis (MS) is a chronic, central nervous system (CNS) disorder characterized by
white matter inflammation, demyelination and neurodegeneration [1]. Among the various
clinical manifestations of MS, cognitive dysfunction is common, affecting around 50% of
patients [2]. It significantly disrupts instrumental everyday activities, work, social interaction,
and overall quality of life [3,4]. Deficits most commonly observed in cognitive function are
related to memory, verbal fluency, speed of information processing, and visuo-spatial and exec-
utive functions [5].
Studies with recently diagnosed MS patients, including subjects with clinically isolated syn-
drome (CIS), have detected cognitive impairment at the onset of the disease. Potagas et al
found that 27% of patients with CIS and 40% of patients with relapsing remitting multiple scle-
rosis (RRMS) had some degree of cognitive impairment [6], mainly in complex attention and
processing speed. Incipient cognitive impairment has even been observed as early as one
month after the first neurological symptom. Achiron and Barak found that 19.4% of patients
assessed shortly after the first neurological symptom failed one neuropsychological test and
34.3% failed two tests. Nevertheless, this impairment had no effect on daily living activities [7].
Several authors have postulated that the development of compensatory mechanisms could
help ameliorate cognitive deficits in the initial stages of the disease [8–10]. While the exact
nature of these mechanisms remains largely unknown, fMRI studies point to the recruitment
of additional brain areas. One study involving an attentional task and three participant
groups—healthy controls, mildly cognitively impaired patients, and severely cognitively
impaired patients- showed extended brain activation areas in the mildly impaired patient sam-
ple. This population showed behavioral performance that was analogous to that of the control
group, but BOLD signals were larger and more widespread. The increased BOLD responses
were observed over frontal and parietal brain areas and were absent in patients with severe cog-
nitive impairment [9]. Increased activation in the early-stage patients was also observed within
the frontal lobes in the dorsolateral prefrontal and anterior cingulate, both of which play a rele-
vant role in performance monitoring [11].
Evidence of frontally-mediated compensatory mechanisms is also provided by neurophysio-
logical studies. In an investigation using the P300 event-related brain potential (ERP) and a
sample of 89 MS patients and their controls, the patient group showed an enhanced P300 fron-
tal amplitude in a choice reaction time task [10]. Interestingly, the amplitude of the P300 corre-
lated positively with cognitive performance in the patient group but not in the controls.
In the last two decades, the performance monitoring system has been studied intensively
using more specific neurophysiological measures than the P300, such as the error-related nega-
tivity or ERN. This component of the ERP is observed following behavioral errors [12]. The
ERN has been interpreted as a correlate of the error detection process [13]. It has a frontocen-
tral topography and its generators have been located in the anterior cingulate cortex and adja-
cent structures in the frontal lobe [14].
In the present study we postulated the implementation of compensatory neural mechanisms
in early-stage MS. To test this hypothesis we assessed the functionality of the performance
monitoring system in these patients using two neurophysiological measures. We recorded the
electroencephalogram and we measured the P300 (P3b and P3a) and the ERN while partici-
pants performed two different behavioral tasks. We postulated that the greater specificity of
the ERN as a performance monitoring correlate would allow us to detect compensatory mecha-
nisms in the early stages of the disease even in the absence of modifications in the P300.
Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis
PLOS ONE | DOI:10.1371/journal.pone.0136786 August 31, 2015 2 / 15
this study. There are no other competing interests.
This does not alter the authors’ adherence to PLOS
ONE policies on sharing data and materials.
Materials and Methods
Participants
Patients regularly attending the Multiple Sclerosis Unit at Hospital de la Santa Creu i Sant Pau
were prospectively recruited fromMay 2011 to May 2013. Inclusion criteria were: relapsing-
remitting MS (RRMS) patients diagnosed according to modified McDonald’s criteria [15] and
less than 3 years of evolution since diagnosis. Participants were excluded if they presented any
other neurological or psychiatric condition, and if they had a previous history of head trauma
or drug abuse including alcohol. We also excluded patients with motor or sensory defects that
could interfere with the administration of the task and those who had a relapse or had taken
corticosteroid treatment in the previous month. A group of healthy individuals, carefully
matched by age, education and sex, were also included into the study.
Protocol approval and patient consent
All the procedures conducted were previously approved by the Ethics Review Board of Hospital
de la Santa Creu i Sant Pau and each participant signed an informed consent.
Neurological assessment
Medical history and current clinical status were assessed in all participants by the same neurol-
ogist specialized in MS (AE).Clinical status was defined by the Expanded Disability Status Scale
(EDSS) [16]. Additionally, the Multiple Sclerosis Severity Score (MSSS) was obtained [17].
Neuropsychological assessment
Cognition and behavior were assessed by a neuropsychologist specialized in MS (ML-G).
Neuropsychological assessment was performed using the Spanish version of the Brief Repeat-
able Battery of Neuropsychological Tests [18] (BRB-N). This battery includes the following
tests:
1. Selective Reminding Test (SRT) that assesses verbal memory acquisition and delayed recall.
Three measurements are obtained: 1) long-term storage 2) long term retrieval and 3) the
number of words recalled after the delay interval.
2. The 10/36 Spatial Recall Test which measures visual memory acquisition and delayed recall.
The score is the total number of correct answers after the three trials and after the delay
interval.
3. Symbol Digit Modalities Test (SDMT) that assesses attention and complex visual scanning.
The score is the number of correct substitutions. The oral form was used.
4. Paced Auditory Serial Addition Test (PASAT) that measures attention, information pro-
cessing speed and working memory. The score is the total number of correct answers.
5. Word List Generation (WLG) that assesses semantic verbal fluency. The subject has to pro-
duce as many words as possible of a given category (fruits and vegetables) in 90 seconds.
The score is the total number of correct answers.
6. Finally, beside the WLG from the BRB-N, we administered the phonetic verbal fluency test.
The score is the total number of correct answers.
Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis
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Assessment of depression and fatigue
As cognitive performance may be influenced by depression and fatigue [4] all participants also
answered specific questionnaires for these symptoms. To assess depression we used the Beck
Depression Inventory or BDI [19], a 21-item self-report instrument designed to measure the
presence of symptoms of depression. To assess fatigue we used the Fatigue Severity Scale (FSS)
[20], a 9-item scale that rates severity and the impact of fatigue on the patient’s life.
Event-Related Brain Potentials
Stop task. We used a modified version of the Eriksen flanker task [21]. Participants were
required to focus on the arrow in the center of an array of five arrows, designated “target”, and
to respond signaling with the right hand after a right-directed arrow and with the left hand
after a left-directed arrow. The four surrounding arrows either favored the target response
(compatible trials,!!!!! or     ) or primed the other response (incompatible
trials,!! !! or  !  ). The task included 33% of compatible trials and 50% of
incompatible trials. In the remaining 17% of trials we included “stop” trials. In these trials the
central green arrow changed to red (for instance:     ) after a delay of 150ms and par-
ticipants had to inhibit the response in these trials. Duration of the stimuli was 300 ms. A ran-
dom SOA between 900 ms and 1100 ms was used. The experiment proper consisted of 3 blocks
of 4 minutes and 200 stimuli each. A 30-second rest period was allowed between blocks. Sub-
jects were required to respond to the stimuli as fast as possible and inhibit their responses
whenever a stop trial appeared.
Auditory oddball task. We used a modified auditory oddball task including unexpected
novel, as described by Marco-Pallarés and coworkers [22]. Subjects were instructed to respond
to infrequent target tones with the following characteristics: 1620 Hz, 60-msduration, 5-ms
rise/fall times and an intensity of 60 dB sound pressure level (SPL). These stimuli occurred
with a probability of 0.1and were embedded in a stream of standard tones of lower pitch: 1500
Hz, 60-ms duration, 5-ms rise/fall times and 60 dB SPL. These standard tones occurred with a
probability of 0.8. In addition, irrelevant natural novel sounds, such as the barking of a dog or
the honking of a car, were delivered with a probability of 0.1. The duration of novel sounds was
between 120 and 410 ms and had an intensity of 60 dB SPL. Subjects were instructed to ignore
standard and novel tones and to respond as quickly and accurately as possible with their right
index finger to target tones. The duration of the task was 15 minutes.
Electrophysiological Recording and processing
The electroencephalogram (EEG) was recorded from 19 standard scalp sites (Fp1/2, F3/4, C3/
4, T3/4, T5/6, P3/4, O1/2, F7/8, Fz, Cz, Pz) using passive tin electrodes mounted in an elastic
cap and referenced to the two mastoid leads. Vertical eye movements were monitored using a
bipolar montage with two electrodes linked together and placed below each eye referenced to a
third electrode placed centrally above the eyes. Horizontal eye movements were monitored
using two electrodes placed on the external canthi of each eye. Electrode impedances were kept
below 5 kOhm. The electrophysiological signals were filtered with a bandpass of 0.1–35 Hz and
digitized at a rate of 250 Hz.
To maximize the information available for the subsequent event-related potential analysis
(ERPs), raw EEG signals were subjected to an ocular artifact minimization process based on
Blind Source Separation (BSS). This technique expresses a set of signals as a linear combination
of statistically independent component signals. For this purpose, the SOBI algorithm [23] was
used. This algorithm is based on an eigenvalue decomposition of time-delayed covariance
matrices. After identifying the source signals associated with eye movements, corrected EEG
Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis
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signals were obtained from the remaining components. Identification of ocular signal sources
was based on frequency and scalp topography analyses as previously described [24].The algo-
rithm was implemented using Matlab.
Following the artifact minimization procedure, signals were processed using Brain Vision
Analyzer software. Stimulus-locked ERPs were obtained for the auditory oddball task. The con-
tinuous EEG recording was segmented in epochs of 1024 ms starting 100 ms prior to stimulus
presentation until 924 ms post-stimulus. Epochs were baseline-corrected, subtracting the mean
amplitude in the 100 ms before stimulus presentation. A two-step artifact rejection procedure
was then used. First epochs were rejected if the signal in any of the 19 channels showed amplitude
values greater than ±300 μV. Subsequently, additional epochs were excluded if amplitude values
were greater than ±75 μV in any of the following channels: Fz, Cz and Pz. After these preprocess-
ing steps, three types of trials were averaged separately: epochs containing frequent stimuli,
epochs containing infrequent stimuli, and epochs containing novel stimuli. These averages were
obtained for each study participant and the ERP components were identified and quantified. The
P3b was identified as the most positive deflection in the ERP between 300 and 600 ms post-stim-
ulus in the infrequent trials. The P3a was identified as the most positive deflection in the ERP
between 240 and 500 ms post-stimulus in the novel trials. The peak value relative to pre-stimulus
baseline was calculated at Cz and Pz for the P3b (centro-parietal distribution) and at Fz and Cz
for the P3a. Latencies were defined as the time taken to reach the peak value after stimulus pre-
sentation. Peak and latency values were introduced into the statistical analysis (see section 2.5.4.).
Response-locked ERPs were obtained for the stop task. The continuous EEG was segmented
in epochs of 1024 ms, starting 200 ms prior to: a) commission of stop errors, and b) correct
responses, until 824 ms thereafter. Thus, the 0 time point corresponded to: a) a button press
when the participant should have withheld the response, and b) the emission of a correct
response. Baseline correction was performed subtracting the mean amplitude in the 50 ms
before button press. Subsequently, the same two-step artifact rejection and procedure described
above was used. Following preprocessing, the epochs were averaged in order to obtain the ERN
wave following commission errors and the absence thereof following correct responses.
Again, these averages were obtained for each study participant and the ERN was identified
and quantified. The ERN was identified as the negative deflection in the ERP appearing
between 0 and 100 ms following a commission error. Two quantification methods were used at
Fz and Cz, because the ERN shows a frontocentral distribution. First, the average voltage was
calculated between 0 and 100 ms following commission errors and correct responses. Second,
peak values for the ERN were obtained relative to the pre-response baseline. This second
method was only used for stop errors, as correct responses show no ERN. The obtained average
and peak values were introduced into the statistical analysis described below.
A series of behavioral variables were obtained in the auditory oddball and stop tasks:
Auditory oddball task: a) percentage of non-responded target stimuli; b) percentage of erro-
neously responded novel stimuli.
Stop task: a) the total number of emitted responses; b) the percentage of trials responded to
correctly; c) reaction times of correct responses; d) reaction times of error correction; e) the
percentage of stop signal commission errors; f) post stop-error slowing; g) the difference in
reaction time between incompatible and compatible trials; h) the difference in the percentage
of errors between incompatible and compatible trials.
Statistical analysis
Data are presented in summaries as means±standard deviation (SD). Demographic, clinical,
neuropsychological and behavioral data were analyzed using independent samples, Student’s
Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis
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t tests and the χ2 test (gender distribution). ERP data from the auditory oddball task were ana-
lyzed using the within-subjects Condition factor (standard/target/novel) and the between-sub-
jects Group factor (MS vs. controls). Analysis of ERP data from the stop task were analyzed
using the within-subjects Condition factor (correct/error) and the between-subjects Group fac-
tor (MS vs. controls). Pairwise post-hoc comparisons were conducted using independent sam-
ples t tests. Results were considered significant for p values<0.05
Results
Demographic and clinical data
The study included 27 patients with diagnosis of RRMS and 31 healthy controls matched for
age, sex and years of education (see Table 1). Twenty patients were receiving immunomodula-
tors, and 7 had not yet initiated treatment. Of those receiving immunomodulators, 1 was addi-
tionally taking carbamazepine to treat trigeminal neuralgia pain, another was taking pregabalin
to treat neuropathic pain, and another was on sildenafil to treat erectile dysfunction.
Table 1. Clinical and neuropsychological assessment for each participant group. Values expressed as mean (SD). Statistical comparisons were con-
ducted using independent samples t-tests (df = 56) and the χ2 (df = 1) tests (gender distribution).
MS patients Controls t/ χ2 p value
Demographic variables
Gender (men/women) 11/16 12/19 0.169 0.788
Age (years) 34.5 (7.5) 37.5 (8.9) -1.397 0.168
Years of education 14.4 (2.8) 14.9 (3.0) -0.627 0.533
Neurological assessment
Disease duration (months) 15.2 (9.4) - - -
Time since last relapse (months) 8.6 (6.4) - - -
EDSS 0.87 (0.91) - - -
MSSS 2.48 (2.22) - - -
Neuropsychological assessment
SRT-Storage 49.6 (11.1) 52.4 (10.1) -0.990 0.326
SRT-Retrieval 41.4 (12.4) 45.7 (11.5) -1.348 0.183
SRT-Delayed 10.0 (1.6) 10.0 (1.8) -0.072 0.943
10/36 24.4 (4.8) 24.7 (4.4) -0.243 0.809
10/36 Delayed 8.4 (2.1) 8.4 (1.4) -0.005 0.996
SDMT 62.5 (9.7) 65.7 (8.6) -1.332 0.188
PASAT 3 seconds 48.6 (7.9) 49.5 (9.0) -0.380 0.705
PASAT 2 seconds 33.4 (18.5) 37.3 (14.4) -0.894 0.375
Semantic Fluency Test 21.3 (4.6) 21.3 (3.8) -0.024 0.981
Phonetic Fluency Test 13.9 (5.6)* 17.0 (3.8) -2.515 0.015
Mood and Fatigue assessment
BDI 7.0 (7.2) 4.4 (5.2) 1.589 0.118
FSS 2.9 (1.6) 2.3 (1.0) 1.666 0.103
EDSS: Expanded Disability Status Scale; MSSS: Multiple Sclerosis Severity Score; SRT: Selective Reminding Test; 10/36: 10/36 Spatial Recall Test;
SDMT: Symbol Digit Modalities Test; PASAT: Paced Auditory Serial Addition Test; Beck: Beck Depression Inventory; FSS: Fatigue Severity Scale
*p<0.05
doi:10.1371/journal.pone.0136786.t001
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Cognitive performance and behavior
As shown in Table 1, no statistically significant differences between groups were found for any
of the variables derived from the neuropsychological tests administered, except for phonetic
verbal fluency. MS patients scored slightly lower in this test than their matched healthy
controls.
No differences were found in scores on the BDI and FSS scales measuring depression and
fatigue, respectively.
ERP analysis of the Stop Task
Table 2 shows the behavioral measures associated with the stop task. No statistically significant
differences were found between groups for any of the behavioral measures assessed. The “per-
centage correct choice responses” refers to stimuli responded to with the correct hand, whereas
the “percentage stop signal commission errors” refers to stop signals where the participant
failed to withhold a response and produced a button press. “Post-error-slowing” is the time
increment observed in correct choice responses when these follow an erroneous trial relative to
when they follow a correct trial (correct and error refer in this case to stimulus-response hand
assignment).
The preprocessing steps involving eye-blink minimization and artifact correction yielded an
epoch rejection of only 3%. The grand averages calculated for each sample in the stop task
showed that shortly after the presentation of a stop signal, commission errors were associates
with an enhanced negative wave. This wave showed the typical topographical distribution of
the ERN with larger values at frontocentral locations. As shown in Fig 1, the grand average of
the ERN was larger for the MS group than for the controls. Given that the ERN is a negative
component, a larger signal is associated with a more negative value. The topographical map in
Fig 1 shows the peak activity of the ERN expressed as the difference wave between error—cor-
rect responses.
The two-way ANOVA using the within-subjects Condition factor (correct/error) and the
between-subjects Group factor (MS vs. controls) conducted at Fz and Cz did not show an
Table 2. Behavioral measures for each participant group in the two neurophysiological tasks. Values expressed as mean (SD). Reaction times (RT)
and post-stop-error slowing are expressed in milliseconds. Statistical comparisons were conducted using independent samples t-tests.
MS patients Controls t value (df = 56) p value
Stop Task
Total responses 585 (41) 586(26) -0.128 0.898
Percentage of correct choice responses 95.0 (4.6) 93.4 (5.2) 1.270 0.209
aRT correct choice responses 474 (53) 460 (55) 1.020 0.312
bRT corrected choice errors 300 (145) 279 (174) 0.472 0.638
Percentage stop signal commission errors 48.7 (14.4) 47.0 (16.5) 0.413 0.681
Post-stop-error slowing 44 (41) 34 (41) 0.912 0.366
aRT incompatible—compatible trials 29 (13) 31 (16) -0.594 0.555
% Errors incompatible—compatible trials 3.35 (4.45) 5.96 (5.76) -1.908 0.062
Auditory oddball task
Percentage non-responded targets 10.47 (9.84) 12.73 (19.87) -0.538 0.593
Percentage responded novel stimuli 4.23 (3.56) 3.69 (3.09) 0.603 0.545
*p<0.05
aRT: reaction time
bRT corrected errors: the reaction time taken to correct an erroneous response
doi:10.1371/journal.pone.0136786.t002
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overall effect of Group: Fz [F(1,56) = 3.29, p = 0.075], Cz [F(1,56) = 3.74, p = 0.058]. Neverthe-
less, it showed significant effects of Condition: Fz [F(1,56) = 30.68, p<0.001], Cz [F(1,56) =
53.64, p<0.001]; and the interaction Group by Condition: Fz [F(1,56) = 4.77, p = 0.033], Cz
[F(1,56) = 5.11, p = 0.028]. This interaction indicated a selective effect after the erroneous
responses only. Mean voltage values were calculated at the Fz and Cz leads for each participant
between 0 and 100 ms following error commission and following correct responses. Mean±SD
voltage values following error commission were -2.77±2.70 μV for MS patients and -1.35
±2.31 μV for the controls at Fz, and -3.37±2.99 μV for MS patients and -1.61±2.71 μV for the
controls at Cz. The statistical comparison between groups (MS vs. controls) showed significant
differences at both leads: Fz [t(56) = -2.17, p = 0.034], and Cz [t(56) = -2.35, p = 0.022]. On the
contrary, no statistically significant differences were found between groups for correct
responses either at Fz [t(56) = -0.508, p = 0.614] or at Cz [t(56) = -0.480, p = 0.633].
The above findings regarding the ERN were confirmed by the alternative approach of mea-
suring peak values in the 0–100 ms time window. Again, MS patients showed larger amplitudes
for the ERN than their healthy controls. Peak values (Mean±SD) were -5.47±3.12 μV for MS
Fig 1. ERPs associated with the stop task.Grand-mean average response-locked ERPs at Fz, Cz and Pz
for stop-errors and correctly responded stimuli. The negative-going deflection following a stop error is the ERN.
Note the increased amplitude of this wave in the MS patients (solid line) as compared to the healthy controls
group (dotted line). The grand-averages have been band-pass filtered (2–8 Hz) for display purposes. The
topographical map shows the peak activity of the ERN expressed as the difference wave between error—
correct responses. Relative scaling was used. Minimum andmaximum values: -5/0 μV.
doi:10.1371/journal.pone.0136786.g001
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patients and -3.56±2.83μV for the controls at Fz [t(56) = -2.42, p = 0.019] and -6.91±3.96 μV
for MS patients and -4.15±3.56 μV for controls at Cz [t(56) = -2.76, p = 0.008].
To test whether the topographical distribution of the ERN differed between groups, we
introduced the mean amplitude from 0 to a 100 ms post error into an ANOVA with electrode
(19 levels) and group (MS vs. controls) as factors, and we searched for a significant interaction
electrode x group as previously described [25].The ANOVA showed a significant effect of elec-
trode, F(18,1008) = 3.35, p = 0.021, and a significant effect of group, [F(1,56) = 4.391,
p = 0.041]. However, it showed a non-significant interaction electrode x group [F(18,1008) =
1.034, p = 0.378]. Thus, the ERN topographies were not significantly different between groups.
ERP analysis of the Auditory oddball task
Table 2 shows the behavioral measures associated with the auditory oddball task. No statisti-
cally significant differences were found between groups for any of the behavioral measures
assessed.
The preprocessing steps involving eye-blink minimization and artifact correction yielded an
epoch rejection of only 2%. Fig 2 illustrates ERPs associated with the standard, target, and
novel stimuli in the auditory oddball task. A centro-parietal P3b component is present in the
target waveforms, whereas a more frontally distributed P3a is seen for the novel stimuli. Visual
inspection of the grand averages did not reveal any differences between MS patients and con-
trols. This was confirmed by the statistical analyses of the latency and magnitude of the ERP
components.
The two-way ANOVA with the within-subjects Condition factor (standard/target/novel)
and the between-subjects Group factor (MS vs. controls) conducted at Fz, Cz and Pz for peak
Fig 2. ERPs associated with auditory the oddball task.Grand-average stimulus-locked ERPs at Fz, Cz
and Pz following the presentation of standard tones (solid black lines), target tones (solid grey lines), and
novel tones (dotted grey lines). Amplitude of the P3b component (target tones) was maximum at Pz, whereas
amplitude of the P3a component (novel tones) was maximum at Cz. No differences in amplitudes or latencies
were found between MS patients and controls.
doi:10.1371/journal.pone.0136786.g002
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latency showed significant effects of Condition: Fz [F(2,112) = 172, p<0.001], Cz [F(2,112) =
187, p<0.001], Pz [F(2,112) = 196, p<0.001]. No effect of Group was observed: Fz [F(1,56) =
0.696, p = 0.408], Cz [F(1,56) = 0.028, p = 0.869], Pz [F(1,56) = 0.004, p = 0.947]; nor their
interaction: Fz [F(2,112) = 1.120, p = 0.319], Cz [F(2,112) = 0.856, p = 0.405], Pz [F(2,112) =
0.535, p = 0.568]. Mean±SD values for P3a latency at Cz were 331±40 ms for patients and
324±49 ms for controls [t(56) = 0.57, p = 0.567]. Regarding the P3b, mean±SD latency values
at Pz were 464±63 ms for patients and 454±69 ms for controls [t(56) = 0.57, p = 0.571].
The two-way ANOVA with the within-subjects Condition factor (standard/target/novel)
and the between-subjects Group factor (MS vs. controls) conducted at Fz, Cz and Pz for
peak amplitude showed a significant effect of Condition: Fz [F(2,112) = 165, p<0.001], Cz
[F(2,112) = 180, p<0.001], Pz [F(2,112) = 210, p<0.001]. No effect of Group was found: Fz
[F(1,56) = 0.200, p = 0.656], Cz [F(1,56) = 0.008, p = 0.929], Pz [F(1,56) = 0.673, p = 0.415];
nor their interaction: Fz [F(2,112) = 1.61, p = 0.209], Cz [F(2,112) = 1.030, p = 0.355], Pz
[F(2,112) = 0.048, p = 0.947]. Mean±SD values for P3a amplitude at Cz were 13.88 ± 6.40 μV
for patients and 13.77 ± 4.75 μV for controls [t(56) = 0.07, p = 0.946]. Mean±SD values for P3b
amplitude at Pz were 8.95±4.52 μV for patients and 8.39±4.00 μV for controls [t(56) = 0.50,
p = 0.620].
Correlations
Statistically significant correlations were seen between ERN amplitude values and scores on
several clinical parameters. We found a significant negative correlation between time since
last relapse and amplitude of the negativity at Cz [r = -0.472, r2 = 0.223, p = 0.013] and Pz [r =
-0.383, r2 = 0.147, p = 0.048]. That is, the larger the ERN (the more negative its value), the
more time had passed since the last relapse. Additionally, we found a significant positive
correlation between the EDSS score and amplitude of the ERN at Cz [r = 0.400, r2 = 0.160,
p = 0.039] and Pz [r = 0.449, r2 = 0.202 p = 0.019]; and between the MSSS and amplitude of the
ERN at Cz [r = 0.388, r2 = 0.151, p = 0.045] and Pz [r = 0.443, r2 = 0.197 p = 0.021] That is, the
smaller the ERN (the less negative its value), the higher the impairment. Scatterplots for these
correlations are shown in Fig 3.
Discussion
Using a behavioral stop-task associated with ERP recordings, our results showed group differ-
ences in amplitude of the negative-going deflection (ERN) found in trials where subjects failed
to inhibit their responses following a stop signal. Immediately after the commission error,
the ERN was observed in all participants at frontocentral leads replicating studies by other
researchers [26]. This ERP component is considered to be a neurophysiological index of error
detection [12] and conflict monitoring [27], two important aspects of executive function [28].
Early stage MS patients showed higher (more negative) ERN amplitudes than controls in
the absence of any behavioral differences. In other words, analogous performance was associ-
ated with greater neurophysiological activation in the patients. The ERN proved to be a sensi-
tive neurophysiological marker, detecting group differences in a sample carefully selected to
rule out differences in education, mood or fatigue. Interestingly, the amplitude of the signal
was not smaller in the patient group, but significantly larger. This patient population would
thus appear to need larger neural recruitment to maintain performance levels analogous to
those of the healthy population.
MS is a progressive disease associated with gradual cognitive deterioration. This process
leads to impairment in many spheres of cognitive functioning such as attention, language and
executive function [29]. Interestingly, the present neurophysiological findings were seen in
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patients at an early stage of the disease, when most neuropsychological tests did not yet find
any impairment.
The compromise of cognitive function in MS has received increasing attention in recent
years due to its high prevalence. From a neuropsychological approach, a comprehensive
Fig 3. Upper panel: Correlation between amplitude of the ERN at the Cz electrode and time since last
relapse.Middle panel: Correlation between amplitude of the ERN at the Pz electrode and score on the
Expanded Disability Status Scale (EDSS). Lower panel: Correlation between amplitude of the ERN at the Pz
electrode and score on the Multiple Sclerosis Severity Score (MSSS). Data from the 27 MS patients.
doi:10.1371/journal.pone.0136786.g003
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cognitive battery is needed to assess these deficits. In a study by Glanz and colleague [30], 49%
of patients with clinically isolated syndrome or newly diagnosed MS showed impairment in at
least one cognitive measure, compared to 30% of healthy controls. Cognitive deficits were
observed mainly in sustained attention, processing speed and verbal memory. Deloire et al.
found that 59.7% of recently diagnosed MS patients scored below the fifth percentile of the per-
formance distribution of the normal population in two or more tests [31]. In the same study,
when patients were asked about their perceived impairment, only 10% of the subjects did not
refer any complaint. However, many respondents considered their cognitive problems to be
moderate and described them as rarely noticed by others. In contrast with these findings, the
results of the present study only showed differences between controls and patients in the pho-
netic fluency test. Lack of differences in other tests may be due to patients’ cognitive preserva-
tion [32], or to the presence of compensatory mechanisms [9].
Other researchers have used ERPs in the past to assess the compromise of cognitive process-
ing in MS. A study involving different illness subtypes reported that around 56% of patients
had pathologically increased P3b latencies. These increases were mainly observed in secondary
progressive multiple sclerosis [33]. Aminoff and colleagues described electrophysiological
changes in MS patients that correlated with cognitive status, and proposed the use of ERPs for
the assessment of cognitive function [34]. In another study involving a large sample of patients
and a choice reaction time task, researchers unexpectedly found P300 amplitude was high in
frontal leads compared to controls. Whereas a positive correlation was found between ampli-
tude of the P300 and performance in the patient subgroup, none was found in the control
group [10]. The authors interpreted results in the patient population as showing a compensa-
tory mechanism relying on increased frontal activation.
Additional support for a compensatory mechanism has been provided by neuroimaging
studies [8,9,35]. One fMRI study assessed brain activation in MS patients while they performed
an attentional task. A cognitively preserved subgroup showed behavioral performance that was
analogous to that of controls, but the intensity and extension of the fMRI BOLD response was
greater. It involved additional activation clusters in numerous brain regions: the inferior and
superior frontal gyri, the dorsolateral prefrontal cortex and the anterior cingulate gyrus [9]. All
these areas play prominent roles in executive function in general and performance monitoring
in particular [11]. In another study, the authors administered the Paced Auditory Serial Addi-
tion Test to MS patients with mild cognitive impairment. Those patients with preserved behav-
ioral performance (i.e., analogous to that of the control group) also showed hyperactivity and
more widespread recruitment of brain areas, especially in frontal regions. This effect was less
intense in the patient subsample that showed poor performance (i.e., worse than that of the
controls) Furthermore, increased frontal activation was positively correlated with lesion bur-
den, as measured by T2 MRI in the overall patient group [35].
Interestingly, in the present study no differences were observed between groups in the rela-
tively simple auditory oddball task. Latency and amplitudes of the P3a and P3b components of
the ERP were not altered in our sample. No modifications were thus observed in stimulus cate-
gorization (P3b) or in the frontal attentional network (P3a). These processes are also thought
to rely on the ACC but in contrast to performance monitoring they are less cognitively
demanding [36,37].
On the contrary, enhanced activation was observed in association with error detection. This
ability is a crucial aspect of performance monitoring. It plays a major role when addressing
environmental demands and guides goal-directed behavior. As proposed by Penner and col-
leagues, increased neural recruitment would precede cognitive decline. The latter would
become manifest when compensatory mechanisms are exhausted [9]. A dramatic deterioration
would be observed later on, usually in the course of the subsequent five years of the disease
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[29]. At later stages, the more automatic and less demanding orienting response would be
affected, and the P3a and P3b would show increased latencies and smaller amplitudes [10].
The above interpretation is supported by the results of the correlation analysis. The more
negative or larger the ERN, that is, the greater the neural recruitment, the longer the patients
stayed relapse-free. On the contrary, those patients showing smaller (less negative) ERN values
had greater EDSS and MSSS scores, indicating a worse clinical status. In line with these find-
ings, a neurophysiological study measuring the P300 found increased ERP in patients relative
to controls [10]. Furthermore, cognitive performance was positively correlated with P300
amplitude, and patients displaying low amplitudes were more cognitively impaired. No such
correlation between P300 amplitude and performance was observed in the control group.
The present study has several limitations. First, an enhanced ERN can be detected in other
pathologies, not only in MS. Second, some patients were receiving pharmacological treatment
while others were not. Finally, it cannot be entirely ruled out that the diverse nature of MS
manifestations may affect the ERN.
To sum up, in the present study we found increased amplitude of the ERN, a neurophysio-
logical correlate of performance monitoring, in a group of early-stage MS patients. This
enhanced signal was observed in the absence of behavioral and cognitive differences between
groups. These findings can be interpreted in terms of greater neuronal recruitment in the
patient group and indicate early compensatory mechanisms in MS. Our results highlight the
sensitivity of ERN to detect early differences in cognitive processes in this sample.
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